Form 4: Elanco Animal Health CEO Acquires Deferred Stock Units

Elanco Animal Health CEO Jeffrey N. Simmons acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Summary

• On May 2, 2025, Jeffrey N. Simmons, CEO and Director of Elanco Animal Health Inc., acquired deferred stock units.
• The transaction involved 284.0246 deferred stock units, each representing the right to receive one share of Elanco common stock or the cash equivalent.
• These deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, according to the Executive Deferral and Stock Match Plan.
• Following the reported transaction, Simmons directly owns 16,034.7565 shares of common stock.
• The price of the derivative security is $9.75.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of deferred stock units could be seen as a positive sign of the CEO's confidence, but it's not a major event.

Positives

• The acquisition of deferred stock units by the CEO could be interpreted as a sign of confidence in the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

Executive compensation in the form of stock options and deferred stock units is a common practice in the animal health industry to align management's interests with those of shareholders.

Comparison to Industry Standards

• Comparing Elanco's executive compensation structure to companies like Zoetis or Merck Animal Health would provide a benchmark for assessing the competitiveness and alignment of incentives.
• Stock grants and option awards are common, but the specific terms and vesting schedules vary widely.

Stakeholder Impact

• The acquisition of deferred stock units by the CEO could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

Elanco Animal Health, Jeffrey N. Simmons, deferred stock units, Form 4, SEC filing, CEO, stock match plan, executive deferral